1. Home
  2. CTXR vs OFAL Comparison

CTXR vs OFAL Comparison

Compare CTXR & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • OFAL
  • Stock Information
  • Founded
  • CTXR 2007
  • OFAL 2013
  • Country
  • CTXR United States
  • OFAL United States
  • Employees
  • CTXR N/A
  • OFAL N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • OFAL Military/Government/Technical
  • Sector
  • CTXR Health Care
  • OFAL Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • OFAL Nasdaq
  • Market Cap
  • CTXR 20.8M
  • OFAL 21.4M
  • IPO Year
  • CTXR N/A
  • OFAL 2025
  • Fundamental
  • Price
  • CTXR $1.17
  • OFAL $1.27
  • Analyst Decision
  • CTXR Strong Buy
  • OFAL
  • Analyst Count
  • CTXR 3
  • OFAL 0
  • Target Price
  • CTXR $53.00
  • OFAL N/A
  • AVG Volume (30 Days)
  • CTXR 461.3K
  • OFAL 368.5K
  • Earning Date
  • CTXR 08-12-2025
  • OFAL 01-01-0001
  • Dividend Yield
  • CTXR N/A
  • OFAL N/A
  • EPS Growth
  • CTXR N/A
  • OFAL N/A
  • EPS
  • CTXR N/A
  • OFAL N/A
  • Revenue
  • CTXR N/A
  • OFAL $202,007.00
  • Revenue This Year
  • CTXR N/A
  • OFAL N/A
  • Revenue Next Year
  • CTXR $851.67
  • OFAL N/A
  • P/E Ratio
  • CTXR N/A
  • OFAL N/A
  • Revenue Growth
  • CTXR N/A
  • OFAL N/A
  • 52 Week Low
  • CTXR $0.65
  • OFAL $1.09
  • 52 Week High
  • CTXR $15.25
  • OFAL $9.79
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 42.40
  • OFAL N/A
  • Support Level
  • CTXR $1.13
  • OFAL N/A
  • Resistance Level
  • CTXR $1.25
  • OFAL N/A
  • Average True Range (ATR)
  • CTXR 0.08
  • OFAL 0.00
  • MACD
  • CTXR -0.00
  • OFAL 0.00
  • Stochastic Oscillator
  • CTXR 14.89
  • OFAL 0.00

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About OFAL OFA Group Ordinary Shares

OFA Group, through its subsidiary, provides architectural services, including design and fit-out services for commercial and residential buildings in Hong Kong. The design service includes both the consultation with staff and the actual design work and the company provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, among other things, budgetary consideration, optimal use of space, the materials, fittings, furniture, appliances and other items to be used to produce a preliminary design plan and quotation. Its works include installing protective materials to cover floors or walls, installing or constructing partition walls, windows, window frames, and decorative fittings, furniture or fixtures, installing plumbing systems, etc.

Share on Social Networks: